Newly launched cardiac MRI-imaging software developer Myocardial Solutions Inc said today it closed a $4 million Series A round to support its SENC diagnostic software application designed for post-processing of cardiac magnetic resonance imaging.
The Raleigh, N.C.-based company claims the software can reduce patient time within MRI machines from a historical 20-60 minutes to less than 5 minutes and can produce objective results without the need for contrast media, breath holding or radiation.
“I am excited to finally have the resources to bring this novel technology to market. The clinical applications for the SENC technology has been proven and validated through our research efforts,” Myocardial Solutions founder Dr. Nael Osman said in prepared remarks.
MSI, freshly founded in January this year, says the it hopes its software expands the use of cardiac magnetic resonance imaging diagnostics, which it says acts as the gold standard for strain imaging resolution and accuracy.
“The rapid quantitative analysis of changes in heart wall motion may open new opportunities to evaluate heart function in asymptomatic patients as a potential preventive measure for heart failure,” prez John Funkhouser said in a press release.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.